Drawing for LAMPLEX

USPTO serial 79292968

LAMPLEX

Reviewed by CopyMark Law Group

Reg. 6481042Status 700Renewal
Filing date
Status date
Registration date
Sep 14, 2021
Examiner
KON, ELISSA GARBER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LAMPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dennis S. Prahl, Esq.

Dennis S. Prahl, Esq. Ladas & Parry LLP1040 Avenue of the AmericasNew York, NY 10018UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic agents for pharmaceutical use; chemical preparations for use in DNA for medical purposes; biological reagents for medical purposes; reagents for use in medical genetic testing; medical diagnostic test strips for blood analysis, urine analysis; diagnostic test reagents for medical purposes for testing body fluids for microorganisms; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical purposes; diagnostic reagents for medical purposes; clinical medical diagnostic reagents; reagents for medical use; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; drugs for medical purposes for treating infectious and metabolic diseasesACTIVE—
010Medical diagnostic apparatus and instruments for monitoring infectious and metabolic diseases; diagnostic apparatus for medical purposes, namely, molecular diagnostic apparatus; in vitro diagnostic devices for medical purposes for monitoring infections; medical instruments for infectious disease testing; medical diagnostic apparatus for testing for bacteria and virus; miniaturized medical sensors for use in gene analysis and diagnosis; medical apparatus and instruments other than for dental purposes for monitoring infectious and metabolic diseases; apparatus for carrying-out diagnostic tests for medical purposes for testing DNA and RNA samples; medical apparatus and instruments in the fields of clinical diagnosis, namely, for diagnostic uses for infectious and metabolic diseases; diagnostic apparatus and instruments for medical purposes for diagnostic uses for infectious and metabolic diseases; medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; medical apparatus, namely, polymerase chain reaction equipment; fluid injectors for medical purposes; syringes for injection of medical substancesACTIVE—
035promoting the goods and services of others by means of operating an on-line comprehensive shopping mall with links to the retail web sites of others; business intermediary services relating to matching of potential private investors with entrepreneurs in the field of mail order by telecommunications who need funding; wholesale store services featuring medical diagnostic test strips; retail store services featuring medical diagnostic test strips; wholesale store services featuring diagnostic test reagents for medical purposes; retail store services featuring diagnostic test reagents for medical purposes; wholesale store services featuring clinical diagnostic reagents; retail store services featuring clinical diagnostic reagents; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring medical diagnostic apparatus and instruments; retail store services featuring medical diagnostic apparatus and instruments; wholesale store services featuring bacteria and virus testing apparatus; retail store services featuring bacteria and virus testing apparatus; wholesale store services featuring medical apparatus and instruments other than for dental purposes; retail store services featuring medical apparatus and instruments other than for dental purposes; wholesale store services featuring syringes for injection of medical substances; retail store services featuring syringes for injection of medical substances; wholesale store services featuring apparatus for medical purposes; retail store services featuring apparatus for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 14, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 26, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 3, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 3, 2022FIMPFINAL DISPOSITION PROCESSED—
Dec 14, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 14, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 29, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 29, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 9, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 26, 2021XAECEXAMINER'S AMENDMENT ENTERED—
May 26, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 26, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
May 26, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
May 26, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 20, 2021PBERWITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST—
May 18, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 17, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 17, 2021ATRVATTORNEY REVIEW COMPLETED—
Mar 17, 2021LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
Mar 11, 2021LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Dec 13, 2020RFNTREFUSAL PROCESSED BY IB—
Nov 23, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 23, 2020RFRRREFUSAL PROCESSED BY MPU—
Nov 5, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 4, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2020DOCKASSIGNED TO EXAMINER—
Sep 8, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 4, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance